Purpose: Neuroendocrine (NE) bladder carcinoma is a rare and aggressive variant.
Molecular subtyping studies have found that 5% to 15% of muscle-invasive bladder cancer …

A growing body of evidence has shown bladder-preservation with chemo-radiotherapy
achieves comparable survival to Radical Cystectomy (5-year OS 50%-70%) and superior …

Urothelial cancer (UC) is the most common histology seen in bladder tumors. The 2022
WHO classification of urinary tract tumors includes a list of less common subtypes (formerly …

Purpose Neuroendocrine (NE)-like carcinoma is a newly recognized molecular subtype of
conventional urothelial carcinoma of the bladder with transcriptomic profiles and clinical …

Introduction Small cell carcinoma of the bladder (SCCB) is a rare variant of bladder cancer
with poor outcomes. We evaluated long-term outcomes of nonmetastatic (M0) and metastatic …

Background Bladder neuroendocrine carcinomas (BNECs) are relatively a rare type of
tumor. The aim of this study was to examine the clinicopathological characteristics and …

Purpose Small cell carcinoma of the bladder (SCCB) is rare, accounting for less than 1% of
all bladder carcinomas. It is aggressive, and outcomes are poor as a result of its early …

Background Extrapulmonary small cell carcinoma is a rare malignancy with scarce data.
Treatment paradigms extrapolate from pulmonary small cell carcinoma and single institution …

Simple Summary The tumor microenvironment (TME) is considered to play a key role in the
development of many types of tumors. Muscle invasive bladder cancer (MIBC), which is well …

Background Neuroendocrine carcinoma of the urinary bladder (NCUB) is rare, accounting
for< 1% of bladder cancer cases, with scarce reported data available. Materials and …